Confluence Investment Management’s iShares iBonds Dec 2030 Term Corporate ETF IBDV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-282,297
Closed -$6.13M 300
2025
Q1
$6.13M Buy
+282,297
New +$6.07M 0.09% 127
2022
Q4
Sell
-763,968
Closed -$15.5M 315
2022
Q3
$15.5M Buy
763,968
+554
+0.1% +$11.9K 0.26% 87
2022
Q2
$16.3M Sell
763,414
-188,422
-20% -$4.12M 0.25% 85
2022
Q1
$22.1M Buy
951,836
+24,538
+3% +$587K 0.31% 68
2021
Q4
$23.3M Buy
927,298
+183,018
+25% +$4.6M 0.31% 75
2021
Q3
$18.8M Buy
744,280
+2,906
+0.4% +$74.5K 0.26% 92
2021
Q2
$18.9M Buy
741,374
+20,696
+3% +$519K 0.25% 95
2021
Q1
$17.9M Buy
720,678
+40,683
+6% +$1.04M 0.25% 97
2020
Q4
$17.9M Sell
679,995
-1,801
-0.3% -$46.7K 0.27% 97
2020
Q3
$17.6M Buy
+681,796
New +$17.6M 0.29% 90

Other funds holding IBDV

Confluence Investment Management's IBDV Position: Q2 2025 in Review

Confluence Investment Management sold out of iShares iBonds Dec 2030 Term Corporate ETF (IBDV) in Q2 2025, closing a stake of 282,297 shares — an estimated $6.13M sold.

Confluence Investment Management first reported a position in IBDV in Q3 2020 and held it in 10 quarters. The position peaked at $23.3M in Q4 2021. 246 funds tracked by Wall St. Rank hold IBDV as of Q2 2025.

  • Confluence Investment Management reported no remaining iShares iBonds Dec 2030 Term Corporate ETF position as of Q2 2025 after selling out during the quarter.
  • Confluence Investment Management sold 282,297 iShares iBonds Dec 2030 Term Corporate ETF shares in Q2 2025, an estimated $6.13M.
  • Confluence Investment Management first reported a position in iShares iBonds Dec 2030 Term Corporate ETF in Q3 2020 and held it in 10 quarters.
  • Confluence Investment Management's iShares iBonds Dec 2030 Term Corporate ETF position peaked at $23.3M in Q4 2021.
  • 246 funds tracked by Wall St. Rank held iShares iBonds Dec 2030 Term Corporate ETF as of Q2 2025.

Based on Confluence Investment Management's 13F filing for Q2 2025, filed 1 Jul 2025.